Completed Access to Information Requests

Follow:

  • RSS
  • Cite
About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA). For additional information, please see the “About Access to Information Requests” webpage.

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 417 record(s)

Req # A-2022-001476

Adverse Drug Reaction (ADR). Report number: 001015840.

Organization: Health Canada

9 page(s)
June 2023

Req # A-2022-001518

Adverse Drug Reactions (ADRs) for PANTOPRAZOLE SODIUM. Report numbers: 001021773, E2B_05967843, E2B_05970491, E2B_05974110, E2B_05993941, E2B_05997808, E2B_06015264, E2B_06023711, E2B_06026393, E2B_06026806.

Organization: Health Canada

922 page(s)
June 2023

Req # A-2022-001522

Adverse Drug Reactions (ADRs) for . Report numbers: E2B_06024544, E2B_06006215, E2B_06007291, 001022865. ADRs for PREVACID. Report numbers: E2B_06024421, 001022857.

Organization: Health Canada

864 page(s)
June 2023

Req # A-2022-001536

Adverse Drug Reactions (ADRs). Report numbers: 001018667, 001013935, E2B_05994869.

Organization: Health Canada

48 page(s)
June 2023

Req # A-2022-001556

Adverse Drug Reaction (ADR). Report number: E2B_06008218.

Organization: Health Canada

31 page(s)
June 2023

Req # A-2022-001578

Adverse Drug Reactions (ADRs). Report numbers: 000997735, 001002447, E2B_05371507.

Organization: Health Canada

27 page(s)
June 2023

Req # A-2022-001600

Adverse Drug Reaction (ADR). Report number: E2B_05763376.

Organization: Health Canada

12 page(s)
June 2023

Req # A-2022-001631

Adverse Drug Reaction (ADR). Report number: E2B_06084589.

Organization: Health Canada

14 page(s)
June 2023

Req # A-2022-001638

Adverse Drug Reactions (ADRs) for CITALOPHRAM. Report numbers: 000983883, E2B_05116306, E2B_03566008, E2B_05130025, 000984705, 000988722, E2B_05404658, E2B_05362070, E2B_03794979, E2B_05362011.

Organization: Health Canada

309 page(s)
June 2023

Req # A-2022-001639

Adverse Drug Reactions (ADRs) for ESCITALOPRAM. Report numbers: E2B_05144321, E2B_03391330, E2B_05121495, E2B_05124444, E2B_04033217, 000984262, 000985042, 000984068, 000988747, 000988396.

Organization: Health Canada

128 page(s)
June 2023
Date modified: